CCP VirusINSIDE CHINA

Chinese People Turn to Indian-Made Generic Drugs After Pfizer’s Paxlovid Excluded from China’s Health Insurance

Save
Chinese People Turn to Indian-Made Generic Drugs After Pfizer’s Paxlovid Excluded from China’s Health Insurance
Pfizer's Paxlovid is displayed in Pembroke Pines, Fl., on July 7, 2022. Joe Raedle/Getty Images
Updated:
News Analysis

Chinese people are searching for Indian-made generic drugs after Paxlovid, Pfizer’s COVID-19 antiviral drug, was recently excluded from China’s national health insurance scheme.

Jenny Li has contributed to The Epoch Times since 2010. She has reported on Chinese politics, economics, human rights issues, and U.S.-China relations. She has extensively interviewed Chinese scholars, economists, lawyers, and rights activists in China and overseas.
Related Topics